Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allonnia has demonstrated commercial readiness with several products including a portable system to remediate groundwater contaminated by PFAS and/or 1,4-dioxane using proprietary microbes or proteins. The company has run one of the largest SAFF treatment systems (>4 million gallons treated), partnered with the U.S. Department of Defense on PFAS remediation projects, contributed to rare earth element recovery projects with the U.S. Army Engineer Research & Development Center, and launched new solutions such as "1,4 D-Stroy" for in situ transformation of toxic chemicals into harmless byproducts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allonnia.